Advanced search
Companies (1)
VALERIO THERAPEUTICS
Valerio Therapeutics (formerly Onxeo) is a clinical-stage biotechnology company developing novel cancer drugs by targeting tumor DNA functions through unparalleled mechanisms of action in the highly sought-after field of DNA damage response (DDR). The com ...
| Capitalization | 18 M USD |
|---|---|
| Change | +3.16% |
| 1-year price change | -32.73% |
- Stock Market
- Advanced search
- Valerio Battista
- Company Profiles